+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Epilepsy Drugs Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Distribution Channel, and Geography- Product Image
Epilepsy Drugs Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Distribution Channel, and Geography- Product Image
Sale

Epilepsy Drugs Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Distribution Channel, and Geography

  • PDF Icon

    Report

  • 139 Pages
  • November 2023
  • Region: Global
  • The Insight Partners
  • ID: 5912300
UP TO OFF until Dec 31st 2024
Description Jump to:
The epilepsy drugs market size was valued at US$ 7.768 billion in 2022 and is projected to reach US$ 10.705 billion by 2030; it is estimated to register a CAGR of 4.1% from 2022 to 2030. The epilepsy drugs market growth is primarily driven by the increasing prevalence of epilepsy and an increasing number of elderly people.

Epilepsy is a neurological condition that can cause seizures and affects millions of people globally. Epilepsy drugs are also known as anti-epileptic drugs (AEDs), which are commonly used for the treatment of epilepsy as it helps in the better management of seizures among epilepsy patients. Some of the patients with drugs resistance epilepsy opt for other treatment methods such as surgery and devices that are implanted in the brain to helps in seizure management.

Several Epilepsy Drugs Nearing Patent Expiration Creating Opportunities for Epilepsy Drugs Market Growth

Many patents expiries are anticipated in the epilepsy drugs market in the upcoming years. It is likely to increase the penetration of generic products to cut down healthcare expenses. This will generate additional opportunities for other market players. Below mentioned are some drugs that are nearing patent expiration in the next couple of years.

Company Patent Patent Expiration Date Ingredient Treatment

Sumitomo Pharma Co US9206135 April 21, 2026 ESLICARBAZEPINE ACETATE Partial-onset Seizures Epilepsy

GlaxoSmithKline US7919115 January 4, 2029 LAMOTRIGINE Epilepsy

Ucb Inc USRE38551 March 17, 2022 Lacosamide Epilepsy and Partial-onset Seizures

SK Biopharmaceuticals US7598279 October 30, 2027 CENOBAMATE Partial Epilepsies

SUPERNUS PHARMS US8877248 November, 2027 Sustained-release formulations of Topiramate Epilepsy

SUPERNUS PHARMS US9555004 November, 2027 Sustained-release formulations of Topiramate Epilepsy

SUPERNUS PHARMS US10314790 November, 2027 Sustained-release formulations of Topiramate Epilepsy

SUPERNUS PHARMS US8663683 November, 2027 Sustained-release formulations of Topiramate Epilepsy

SUPERNUS PHARMS US9622983 November, 2027 Sustained-release formulations of Topiramate Epilepsy

SUPERNUS PHARMS US8298580 November, 2027 Sustained-release formulations of Topiramate Epilepsy

SUPERNUS PHARMS US8992989 November, 2027 Sustained-release formulations of Topiramate Epilepsy

SUPERNUS PHARMS US8889191 November, 2027 Sustained-release formulations of Topiramate Epilepsy

SUPERNUS PHARMS US9549940 November, 2027 Sustained-release formulations of Topiramate Epilepsy

SUPERNUS PHARMS US8298576 April, 2028 Sustained-release formulations of Topiramate Epilepsy

Treatment-Based Insights

The epilepsy drugs market, by treatment, is segmented into first generation anti-epileptics, second generation anti-epileptics, and third generation anti-epileptics. In 2022, the second generation anti-epileptics segment held the largest market share; the third generation anti-epileptics is estimated to register the fastest CAGR during 2022-2030. The second-generation AEDs include felbamate, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, pregabalin, rufinamide, stiripentol, tiagabine, topirate, topiramate, vigabatrin, and zonisamide. In North America and Europe, ZNS is also considered a second-generation drug. The higher cost of second-generation AEDs compared with first-generation drugs is a significant factor limiting their mention in formularies. The second-generation AEDs have a more favorable side-effect profile and a lower risk of teratogenesis compared with first-generation drugs. Many first-generation and several second-generation (AEDs) share a common feature of enzyme induction that can increase the metabolism of different substrates targeted by the cytochrome p450 enzyme, along with a decrease in the action of the inducer.

Distribution Channel-Based Insights

The epilepsy drugs market, by distribution channel, is segmented into hospital pharmacy, retail pharmacy stores, and others. In 2022, the hospital pharmacies segment held the largest market share; the retail pharmacy segment is anticipated to register the fastest CAGR during 2022-2030. Hospital pharmacies purchase pharmaceuticals from different companies and supply them to hospitals for outpatient or inpatient treatments. Hospital pharmacies usually offer therapeutic and critical care drugs that have applications in cardiology, neurology, urology, pathology, hematology, and dermatology. Hospital pharmacies are among the essential parts of the healthcare system of any country. These pharmacies maintain stocks of epilepsy drugs to ensure their ready availability for patients. Thus, hospital pharmacies hold a considerable size of the epilepsy drug market.

A few of the major primary and secondary sources referred to while preparing the report on the epilepsy drugs market are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), Investor presentations and Annual Reports of Market players.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Epilepsy Drugs Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Epilepsy Drugs Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Epilepsy
5.1.2 Increasing Number of Elderly People
5.2 Market Restraints
5.2.1 Recall of Therapeutic Products
5.3 Market Opportunities
5.3.1 Several Epilepsy Drugs Nearing Patent Expiration
5.4 Future Trends
5.4.1 Increasing Product Approvals
5.5 Impact Analysis
6. Epilepsy Drugs Market - Global Market Analysis
6.1 Epilepsy Drugs Revenue (US$ Mn), 2022 - 2030
7. Global Epilepsy Drugs Market - Revenue and Forecast to 2030 - by Treatment
7.1 Overview
7.2 Epilepsy Drugs Market Revenue Share, by Treatment 2022 & 2030 (%)
7.3 First Generation Antiepileptics
7.3.1 Overview
7.3.2 First Generation Antiepileptics: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Second Generation Anti-epileptics
7.4.1 Overview
7.4.2 Second Generation Anti-epileptics: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Third Generation Anti-epileptics
7.5.1 Overview
7.5.2 Third Generation Anti-epileptics: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
8. Global Epilepsy Drugs Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 Epilepsy Drugs Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacy
8.3.1 Overview
8.3.2 Hospital Pharmacy: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacy Stores
8.4.1 Overview
8.4.2 Retail Pharmacy Stores: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9. Epilepsy Drugs Market - Revenue and Forecast to 2030 - Geographic Analysis
9.1 North America: Epilepsy Drugs Market
9.1.1 Overview
9.1.2 North America: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.3 North America: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.1.4 North America: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.4.1 US: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.4.1.1 Overview
9.1.4.1.2 US: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.4.1.3 US: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.1.4.1.4 US: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.4.2 Canada: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.4.2.1 Overview
9.1.4.2.2 Canada: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.4.2.3 Canada: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.1.4.2.4 Canada: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.4.3 Mexico: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.4.3.1 Overview
9.1.4.3.2 Mexico: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.4.3.3 Mexico: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.1.4.3.4 Mexico: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.2 Europe: Epilepsy Drugs Market
9.2.1 Overview
9.2.2 Europe: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.3 Europe: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.2.4 Europe: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.2.5 Europe: Epilepsy Drugs Market, by Country, 2022 & 2030 (%)
9.2.5.1 Germany: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 Germany: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.1.3 Germany: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.2.5.1.4 Germany: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.2.5.2 France: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 France: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.2.3 France: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.2.5.2.4 France: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.2.5.3 UK: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 UK: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.3.3 UK: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.2.5.3.4 UK: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.2.5.4 Italy: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.4.3 Italy: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.2.5.4.4 Italy: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.2.5.5 Spain: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.5.3 Spain: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.2.5.5.4 Spain: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.2.5.6 Rest of Europe: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.2.5.6.3 Rest of Europe: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.2.5.6.4 Rest of Europe: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.3 Asia Pacific: Epilepsy Drugs Market
9.3.1 Overview
9.3.2 Asia Pacific: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Asia Pacific: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.3.4 Asia Pacific: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.3.5 Asia Pacific: Epilepsy Drugs Market, by Country, 2022 & 2030 (%)
9.3.5.1 China: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.1.1 Overview
9.3.5.1.2 China: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.1.3 China: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.3.5.1.4 China: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.3.5.2 Japan: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.2.1 Overview
9.3.5.2.2 Japan: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.2.3 Japan: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.3.5.2.4 Japan: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.3.5.3 India: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.3.1 Overview
9.3.5.3.2 India: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.3.3 India: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.3.5.3.4 India: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.3.5.4 Australia: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.4.1 Overview
9.3.5.4.2 Australia: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.4.3 Australia: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.3.5.4.4 Australia: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.3.5.5 South Korea: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.5.1 Overview
9.3.5.5.2 South Korea: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.5.3 South Korea: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.3.5.5.4 South Korea: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.3.5.6 Rest of Asia Pacific: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia Pacific: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.3.5.6.3 Rest of Asia Pacific: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.3.5.6.4 Rest of Asia Pacific: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.4 Middle East & Africa Epilepsy Drugs Market
9.4.1 Overview
9.4.2 Middle East & Africa: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.4.3 Middle East & Africa: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.4.4 Middle East & Africa: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.4.4.1 South Africa: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.4.4.1.1 Overview
9.4.4.1.2 South Africa: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.4.4.1.3 South Africa: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.4.4.1.4 South Africa: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.4.4.2 Saudi Arabia: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.4.4.2.1 Overview
9.4.4.2.2 Saudi Arabia: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.4.4.2.3 Saudi Arabia: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.4.4.2.4 Saudi Arabia: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.4.4.3 UAE: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.4.4.3.1 Overview
9.4.4.3.2 UAE: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.4.4.3.3 UAE: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.4.4.3.4 UAE: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.4.4.4 Rest of Middle East & Africa: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.4.4.4.1 Overview
9.4.4.4.2 Rest of Middle East & Africa: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.4.4.4.3 Rest of Middle East & Africa: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.4.4.4.4 Rest of Middle East & Africa: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.5 South & Central America: Epilepsy Drugs Market
9.5.1 Overview
9.5.2 South & Central America: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.5.3 South & Central America: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.5.4 South & Central America: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.5.5 South & Central America: Epilepsy Drugs Market Share by Country - 2022 & 2030, (%)
9.5.5.1 Brazil: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.5.5.1.1 Overview
9.5.5.1.2 Brazil: Epilepsy Drugs Market- Revenue and Forecasts to 2030 (US$ Million)
9.5.5.1.3 Brazil: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.5.5.1.4 Brazil: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.5.5.2 Argentina: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.5.5.2.1 Overview
9.5.5.2.2 Argentina: Epilepsy Drugs Market- Revenue and Forecasts to 2030 (US$ Million)
9.5.5.2.3 Argentina: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.5.5.2.4 Argentina: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.5.5.3 Rest of South & Central America: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South & Central America: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.5.5.3.3 Rest of South & Central America: Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.5.5.3.4 Rest of South & Central America: Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Epilepsy Drugs Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Epilepsy Drugs Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 UCB SA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Novartis AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Pfizer Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 GSK Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Abbott Laboratories
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Sanofi SA
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Sumitomo Pharma America Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Catalyst Pharmaceuticals Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Alkem Laboratories Ltd
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
List of Tables
Table 1. Epilepsy Drugs Segmentation
Table 2. North America Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 4. US Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 5. US Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 6. Canada Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 8. Mexico Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 9. Mexico Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 10. Europe Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 11. Europe Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 13. Germany Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 14. France Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 15. France Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 16. UK Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 17. UK Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 18. Italy Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Spain Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Europe Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 24. Asia Pacific Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 25. Asia Pacific Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 26. China Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 27. China Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 28. Japan Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 29. Japan Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 30. India Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 31. India Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 32. Australia Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 33. Australia Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 34. South Korea Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 35. South Korea Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Asia Pacific Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 37. Rest of Asia Pacific Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 38. Middle East & Africa Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 39. Middle East & Africa Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 40. South Africa Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 41. South Africa Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 42. Saudi Arabia Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 43. Saudi Arabia Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 44. UAE Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 45. UAE Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 46. Rest of Middle East & Africa Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 47. Rest of Middle East & Africa Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 48. South & Central America: Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 49. South & Central America: Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 50. Brazil: Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 51. Brazil: Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 52. Argentina: Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 53. Argentina: Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of South & Central America: Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of South & Central America: Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 56. Recent Inorganic Growth Strategies in the Epilepsy Drugs Market
Table 57. Recent Organic Growth Strategies in the Epilepsy Drugs Market
Table 58. Glossary of Terms, Epilepsy Drugs Market
List of Figures
Figure 1. Epilepsy Drugs Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Epilepsy Drugs Market: Key Industry Dynamics
Figure 4. Epilepsy Drugs Market: Impact Analysis of Drivers and Restraints
Figure 5. Epilepsy Drugs Revenue (US$ Mn), 2022 - 2030
Figure 6. Epilepsy Drugs Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 7. First Generation Anti-epileptics: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Second Generation Anti-epileptics: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Third Generation Anti-epileptics: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Epilepsy Drugs Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 11. Hospital Pharmacy: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Retail Pharmacy Stores: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. North America: Epilepsy Drugs Market, by Key Country - Revenue (2022) (US$ Million)
Figure 15. North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. North America: Epilepsy Drugs Market, by Country, 2022 & 2030 (%)
Figure 17. US: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Canada: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Mexico: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe: Epilepsy Drugs Market, by Key Country - Revenue (2022) (US$ Million)
Figure 21. Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Europe: Epilepsy Drugs Market, by Country, 2022 & 2030 (%)
Figure 23. Germany: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. France: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. UK: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Italy: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Spain: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Rest of Europe: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Asia Pacific: Epilepsy Drugs Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. Asia Pacific Epilepsy Drugs Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Asia Pacific: Epilepsy Drugs Market, by Country, 2022 & 2030 (%)
Figure 32. China: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Japan: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. India: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Australia: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 36. South Korea: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 37. Rest of Asia Pacific: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 38. Middle East & Africa: Epilepsy Drugs Market, by Key Country - Revenue (2022) (US$ Million)
Figure 39. Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 40. Middle East & Africa: Epilepsy Drugs Market, by Country, 2022 & 2030 (%)
Figure 41. South Africa: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 42. Saudi Arabia: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 43. UAE: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 44. Rest of Middle East & Africa: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 45. South & Central America: Epilepsy Drugs Market, By Key Country - Revenue (2022) (US$ Million)
Figure 46. South & Central America: Epilepsy Drugs Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 47. South & Central America: Epilepsy Drugs Market Share by Country - 2022 & 2030, (%)
Figure 48. Brazil: Epilepsy Drugs Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 49. Argentina: Epilepsy Drugs Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 50. Rest of South & Central America: Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. Growth Strategies in the Epilepsy Drugs Market

Companies Mentioned

  • UCB SA
  • Novartis AG
  • Pfizer Inc
  • GSK Plc
  • Abbott Laboratories
  • Sanofi SA
  • Sumitomo Pharma company
  • Teva Pharmaceutical Industries Ltd
  • Catalyst Pharmaceuticals Inc
  • Alkem Laboratories Ltd

Table Information

Report AttributeDetails
No. of Pages139
PublishedNovember 2023
Forecast Period2022 - 2030
Estimated Market Value in 2022 7.77 Billion
Forecasted Market Value by 2030 10.71 Billion
Compound Annual Growth Rate4.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis - Product Image

Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis

  • Report
  • 250 Pages
  • Global
From
Epilepsy Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Treatment Type, Age Group, Distribution Channel, and Geography - Product Image

Epilepsy Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Treatment Type, Age Group, Distribution Channel, and Geography

  • Report
  • 230 Pages
  • Global
From
Epilepsy Drug Market by Product Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Epilepsy Drug Market by Product Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Epilepsy Drugs - Global Strategic Business Report - Product Image

Epilepsy Drugs - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Childhood Absence Epilepsy Treatment Market by Drug, Disease Type - Global Forecast 2025-2030 - Product Image

Childhood Absence Epilepsy Treatment Market by Drug, Disease Type - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.